N-Benzoyl-5'-O-[bis(4-methoxyphenyl)(phenyl)methyl]-2'-O-methylcytidine(CAS: 110764-74-4)

Regulatory guidelines for N-Benzoyl-5'-O-[bis(4-methoxyphenyl)(phenyl)methyl]-2'-O-methylcytidine (CAS: 110764-74-4) include compliance with the Globally Harmonized System of Classification and Labelling of Chemicals (GHS) for handling, storage, and disposal. Additionally, it should meet REACH regulations for European market entry, and comply with FDA and EPA guidelines in the United States for any research, development, or commercial applications.

Several alternatives to N-Benzoyl-5'-O-[bis(4-methoxyphenyl)(phenyl)methyl]-2'-O-methylcytidine (CAS: 110764-74-4) exist in synthesis, including related analogs such as N-benzoyl-2'-deoxy-5'-O-[(4-methoxyphenyl)(phenyl)methyl]cytidine, and isomers like N-benzoyl-5'-O-[phenyl(4-methoxyphenyl)methyl]-2'-O-methylcytidine. Common alternative reagents include various benzoyl chlorides and methylating agents.

The market for N-Benzoyl-5'-O-[bis(4-methoxyphenyl)(phenyl)methyl]-2'-O-methylcytidine (CAS: 110764-74-4) is driven by emerging research in antiviral and immunomodulatory fields. Recent trends indicate increasing interest in its potential as a therapeutic agent, with ongoing studies focusing on its efficacy and safety profiles. Market demand is expected to grow with advancements in targeted drug delivery systems and personalized medicine.

Waste containing N-Benzoyl-5'-O-[bis(4-methoxyphenyl)(phenyl)methyl]-2'-O-methylcytidine (CAS: 110764-74-4) should be collected in appropriate, leak-proof containers and stored in a secure, well-ventilated area. For disposal, it is recommended to engage a professional waste management service or incineration facility that adheres to local regulations. Proper environmental protection precautions include ensuring no accidental spills and implementing containment measures to prevent contamination of soil and water sources.